Related Experiment Video
Updated: Oct 6, 2025

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
STAT3 exerts pro-tumor and anti-autophagy roles in cervical cancer
Lin Wu1,2, Bowen Shen3, Junpeng Li2
1The First School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Background:
STAT3 plays an important role in cervical cancer. LC3B, the most potential molecular biomarker of autophagy that may promote or inhibit cancer progression, can be downregulated by STAT3. However the role of STAT3 in the autophagy of cervical cancer remains unclear.
Purpose:
This study aimed to evaluate the relationship between STAT3 and LC3B in protein level, and verify whether STAT3 promotes proliferation, migration and plate colony formation by inhibiting autophagy of cervical cancer cells through bcl2-beclin1 axis.
Results:
STAT3 was overexpressed in cervical cancer tissues, and negatively correlated with the expression level of LC3B. STAT3 knockout or knockdown significantly increased the autophagy level and decreased proliferation, migration, plate colony formation and subcutaneous tumorigenesis of cervical cancer cells in vitro and in vivo. STAT3 is known to mediate autophagy through Bcl2-Beclin1 complex. Bcl2 was positively whereas Beclin1 negatively correlated with STAT3 expression, indicating that Bcl2-Beclin1 complex involved in this transition.
Conclusion:
STAT3 may upregulate the autophagy level of cervical cancer cells through the Bcl2-Beclin1 axis. This indicates that STAT3 may be an important prognostic and therapeutic target for cervical cancer.
Insights
Signal transducer and activator of transcription 3 (STAT3) may increase cervical cancer cell autophagy via the Bcl2-Beclin1 pathway. Inhibiting STAT3 could be a therapeutic strategy for cervical cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- STAT3 is implicated in cervical cancer progression.
- STAT3 can downregulate LC3B, a key autophagy biomarker.
- The precise role of STAT3 in cervical cancer autophagy is not fully understood.
Purpose of the Study:
- To investigate the relationship between STAT3 and LC3B protein levels.
- To determine if STAT3 inhibits cervical cancer cell autophagy via the Bcl2-Beclin1 axis.
- To assess STAT3's impact on cancer cell proliferation, migration, and colony formation.
Main Methods:
- Analysis of STAT3 and LC3B expression in cervical cancer tissues.
- STAT3 knockout/knockdown experiments in vitro and in vivo.
- Assessment of autophagy markers and cancer cell phenotypes.
- Examination of Bcl2-Beclin1 complex interactions.
Main Results:
- STAT3 was overexpressed and negatively correlated with LC3B in cervical cancer.
- STAT3 inhibition/depletion enhanced autophagy and reduced cancer cell proliferation, migration, and tumorigenesis.
- STAT3 positively correlated with Bcl2 and negatively with Beclin1, implicating the Bcl2-Beclin1 complex.
Conclusions:
- STAT3 appears to upregulate cervical cancer cell autophagy through the Bcl2-Beclin1 axis.
- STAT3 represents a potential prognostic and therapeutic target for cervical cancer.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway
Destabilization of Microtubules
Inhibition of Cdk Activity
The Tumor Microenvironment